Jayson Bedford
Stock Analyst at Raymond James
(3.79)
# 686
Out of 5,124 analysts
324
Total ratings
53.59%
Success rate
7.32%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Outperform | $20 → $27 | $34.92 | -22.68% | 2 | Oct 30, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $488.15 | +23.53% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $20.15 | -5.71% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $110.83 | +31.73% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $239.99 | -12.91% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $89.91 | +25.68% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $154.16 | +16.76% | 22 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $82.50 | +23.64% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $69.97 | +45.78% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $76.27 | +62.58% | 26 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $328 → $360 | $241.93 | +48.80% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $204 → $185 | $139.15 | +32.95% | 7 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $210.02 | +28.56% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $10.56 | -5.30% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $108.42 | +149.95% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.82 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $19.17 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $78.71 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.73 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $102.90 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $7.43 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $74.81 | +14.96% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.43 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $11.26 | - | 3 | Jan 2, 2018 |
Axogen
Oct 30, 2025
Maintains: Outperform
Price Target: $20 → $27
Current: $34.92
Upside: -22.68%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $488.15
Upside: +23.53%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $20.15
Upside: -5.71%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $110.83
Upside: +31.73%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $239.99
Upside: -12.91%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $89.91
Upside: +25.68%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $154.16
Upside: +16.76%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $82.50
Upside: +23.64%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $69.97
Upside: +45.78%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $76.27
Upside: +62.58%
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $241.93
Upside: +48.80%
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $139.15
Upside: +32.95%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $210.02
Upside: +28.56%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $10.56
Upside: -5.30%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $108.42
Upside: +149.95%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.82
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $19.17
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $78.71
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $21.73
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $102.90
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $7.43
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $74.81
Upside: +14.96%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.43
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $11.26
Upside: -